A new alternating regimen in metastatic renal cell carcinoma presented through a clinical case

In the article a new alternating regimen which includes alternation between interferon (INF) immunotherapy and target therapy (sunitinib) is described through a clinical case. Mentions of this type of regimen weren’t found in the literature. As a result of the regimen, treatment efficacy increased d...

Full description

Bibliographic Details
Main Authors: M. S. Sayapina, S. V. Shiryaev, A. S. Krylov, A. D. Ryzhkov, D. A. Titov, D. A. Nosov
Format: Article
Language:Russian
Published: ABV-press 2016-12-01
Series:Onkourologiâ
Subjects:
Online Access:https://oncourology.abvpress.ru/oncur/article/view/585